Additionally, genome-wide association study has predicted that PLSCR1 missense variants was associated with severe COVID-19, suggesting an important role PLSCR1 in antagonizing SARS-CoV-2 infection (12, 13, 27). Here, PLSCR1 is linked to COVID-19.